Advent International has agreed to buy a 50% stake in inVentiv Health, a professional services organization serving the global biopharma industry, joining Thomas H. Lee Partners as an equal equity owner. The deal, expected to close during 4Q, values Massachusetts-based inVentiv at $3.8 billion, making it one of the largest private equity transactions involving an American healthcare company in recent years.
Since the start of 2012, PE investors have completed 1,821 deals for companies in the U.S. healthcare sector, according to the PitchBook Platform, with activity reaching a peak of 469 deals during 2015. So far in 2016, 235 deals have been sealed in the space—on pace for a minor drop from last year, but still on track to match 2014 and easily surpass both 2012 and 2013 in terms of deal flow.
Here are the top PE investors in U.S. healthcare since the start of 2012, along with their deal counts (incl. add-ons):